$NURO
NeuroMetrix, Inc. Stock $nuro

$nuro Overview Financials Valuation SEC Filings Company Website

2020 Form 10-K Financial Statement

#000162828021001059 Filed on January 29, 2021

Income Statement

Concept	2020	2019 Q4	2019
Revenue	$7.378M	$1.710M	$9.273M
YoY Change	-20.43%	-54.16%	-42.37%
Cost Of Revenue	$2.128M	$640.0K	$7.027M
YoY Change	-69.71%	-67.68%	-19.3%
Gross Profit	$5.250M	$1.060M	$2.246M
YoY Change	133.77%	-39.43%	-69.58%
Gross Profit Margin	71.15%	61.99%	24.22%
Selling, General & Admin	$4.953M	$1.820M	$10.68M
YoY Change	-53.62%	-48.15%	-26.56%
% of Gross Profit	94.35%	171.7%	475.52%
Research & Development	$2.391M	$630.0K	$3.102M
YoY Change	-22.91%	-40.57%	-39.59%
% of Gross Profit	45.55%	59.43%	138.13%
Depreciation & Amortization	$89.95K	$20.00K	$124.0K
YoY Change	-27.46%		-26.93%
% of Gross Profit	1.71%	1.89%	5.52%
Operating Expenses	$7.344M	$2.460M	$13.78M
YoY Change	-46.7%	-46.17%	-29.96%
Operating Profit	-$2.095M	-$1.400M	-$11.53M
YoY Change	-81.84%	-50.35%	-6.16%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$2.709K	$0.00	$7.762M
YoY Change	-99.97%	-100.0%	12836.16%
Pretax Income	-$2.090M	-$1.060M	-$3.770M
YoY Change	-44.56%	-62.14%	-18950.0%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$2.092M	-$1.060M	-$3.773M
YoY Change	-44.55%	-62.14%	-16083.96%
Net Earnings / Revenue	-28.36%	-61.99%	-40.69%
Basic Earnings Per Share	-$0.69		-$3.90
Diluted Earnings Per Share	-$0.69	-$1.093M	-$3.90
COMMON SHARES
Basic Shares Outstanding	3.014M shares	9.782M shares	968.1K shares
Diluted Shares Outstanding	3.014M shares		968.1K shares

Balance Sheet

Concept	2020	2019 Q4	2019
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.230M	$3.130M	$3.130M
YoY Change	67.09%	-53.83%	-53.83%
Cash & Equivalents	$5.230M	$3.126M	$3.130M
Short-Term Investments
Other Short-Term Assets	$480.0K	$650.0K	$650.0K
YoY Change	-26.15%	-24.42%	-24.42%
Inventory	$1.050M	$1.164M	$1.160M
Prepaid Expenses
Receivables	$330.0K	$299.0K	$300.0K
Other Receivables	$0.00	$190.0K	$190.0K
Total Short-Term Assets	$7.090M	$5.431M	$5.430M
YoY Change	30.57%	-53.13%	-53.15%
LONG-TERM ASSETS
Property, Plant & Equipment	$880.0K	$273.4K	$1.430M
YoY Change	-38.46%	-32.87%	-39.92%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$30.00K	$30.00K	$30.00K
YoY Change	0.0%	0.0%	0.0%
Total Long-Term Assets	$900.0K	$1.463M	$1.460M
YoY Change	-38.36%	-39.19%	-39.17%
TOTAL ASSETS
Total Short-Term Assets	$7.090M	$5.431M	$5.430M
Total Long-Term Assets	$900.0K	$1.463M	$1.460M
Total Assets	$7.990M	$6.894M	$6.890M
YoY Change	15.97%	-50.73%	-50.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$140.0K	$725.7K	$730.0K
YoY Change	-80.82%	-44.1%	-43.85%
Accrued Expenses	$2.140M	$1.444M	$2.720M
YoY Change	-21.32%	-12.99%	-18.56%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.290M	$3.447M	$3.450M
YoY Change	-33.62%	-47.72%	-47.65%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$460.0K	$920.0K	$920.0K
YoY Change	-50.0%	-29.23%	-29.23%
Total Long-Term Liabilities	$460.0K	$920.0K	$920.0K
YoY Change	-50.0%	-29.23%	-29.23%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.290M	$3.447M	$3.450M
Total Long-Term Liabilities	$460.0K	$920.0K	$920.0K
Total Liabilities	$2.750M	$4.363M	$4.360M
YoY Change	-36.93%	-44.72%	-44.74%
SHAREHOLDERS EQUITY
Retained Earnings		-$194.8M
YoY Change		1.98%
Common Stock		$140.00
YoY Change		89.19%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$5.250M	$2.530M	$2.530M
YoY Change
Total Liabilities & Shareholders Equity	$7.990M	$6.894M	$6.890M
YoY Change	15.97%	-50.73%	-50.75%

Cashflow Statement

Concept	2020	2019 Q4	2019
OPERATING ACTIVITIES
Net Income	-$2.092M	-$1.060M	-$3.773M
YoY Change	-44.55%	-62.14%	-16083.96%
Depreciation, Depletion And Amortization	$89.95K	$20.00K	$124.0K
YoY Change	-27.46%		-26.93%
Cash From Operating Activities	-$2.067M	-$60.00K	-$3.621M
YoY Change	-42.92%	-91.67%	-226.54%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	-$10.00K	$48.08K
YoY Change	-100.0%	-66.67%	-66.52%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	-$10.00K	-$48.08K
YoY Change	-100.0%	-66.67%	-66.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$4.167M	10.00K	$15.11K
YoY Change	27484.19%	0.0%	-18.86%
NET CHANGE
Cash From Operating Activities	-$2.067M	-60.00K	-$3.621M
Cash From Investing Activities	$0.00	-10.00K	-$48.08K
Cash From Financing Activities	$4.167M	10.00K	$15.11K
Net Change In Cash	$2.100M	-60.00K	-$3.654M
YoY Change	-157.47%	-91.89%	-233.52%
FREE CASH FLOW
Cash From Operating Activities	-$2.067M	-$60.00K	-$3.621M
Capital Expenditures	$0.00	-$10.00K	$48.08K
Free Cash Flow	-$2.067M	-$50.00K	-$3.669M
YoY Change	-43.67%	-92.75%	-234.99%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020	dei	Entity Central Index Key EntityCentralIndexKey	0001289850
CY2020	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2020	dei	Amendment Flag AmendmentFlag	false
CY2020	us-gaap	Substantial Doubt About Going Concern Within One Year SubstantialDoubtAboutGoingConcernWithinOneYear	true
CY2020	dei	Document Type DocumentType	10-K
CY2020	dei	Document Annual Report DocumentAnnualReport	true
CY2020	dei	Document Period End Date DocumentPeriodEndDate	2020-12-31
CY2020	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020	dei	Document Transition Report DocumentTransitionReport	false
CY2020	dei	Entity File Number EntityFileNumber	001-33351
CY2020	dei	Entity Registrant Name EntityRegistrantName	NEUROMETRIX, INC.
CY2020	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2020	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	04-3308180
CY2020	dei	Entity Address Address Line1 EntityAddressAddressLine1	4B Gill Street
CY2020	dei	Entity Address City Or Town EntityAddressCityOrTown	Woburn
CY2020	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
CY2020	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	01801
CY2020	dei	City Area Code CityAreaCode	781
CY2020	dei	Local Phone Number LocalPhoneNumber	890-9989
CY2020	dei	Entity Shell Company EntityShellCompany	false
CY2021Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3796147	shares
CY2020	dei	Security12g Title Security12gTitle	Common Stock, $0.0001 par value per share
CY2020	dei	Trading Symbol TradingSymbol	NURO
CY2020	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2020	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2020	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2020	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2020	dei	Entity Small Business EntitySmallBusiness	true
CY2020	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020Q2	dei	Entity Public Float EntityPublicFloat	7690938	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5226213	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3126206	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	25000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	70000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	334297	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	298967	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	1051282	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	1163714	USD
CY2020Q4	nuro	Collaborator Payments Receivable CollaboratorPaymentsReceivable	0	USD
CY2019Q4	nuro	Collaborator Payments Receivable CollaboratorPaymentsReceivable	189008	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	478074	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	652919	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	7089866	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	5430814	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	183494	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	273448	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	692692	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1159774	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	28523	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	29650	USD
CY2020Q4	us-gaap	Assets Assets	7994575	USD
CY2019Q4	us-gaap	Assets Assets	6893686	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	142316	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	725658	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	998442	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1443574	USD
CY2020Q4	nuro	Accrued Sales Return Provisions AccruedSalesReturnProvisions	545000	USD
CY2019Q4	nuro	Accrued Sales Return Provisions AccruedSalesReturnProvisions	689000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	599632	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	588546	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2285390	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3446778	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	461410	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	916674	USD
CY2020Q4	us-gaap	Liabilities Liabilities	2746800	USD
CY2019Q4	us-gaap	Liabilities Liabilities	4363452	USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3793739	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3793739	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1400674	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1400674	shares
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	379	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	140	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	202129195	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	197319698	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-196881800	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-194789605	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	5247775	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	2530234	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7994575	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6893686	USD
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	7377975	USD
CY2019	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	9272522	USD
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	2128417	USD
CY2019	us-gaap	Cost Of Revenue CostOfRevenue	7026899	USD
CY2020	us-gaap	Gross Profit GrossProfit	5249558	USD
CY2019	us-gaap	Gross Profit GrossProfit	2245623	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2391316	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3101976	USD
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1436806	USD
CY2019	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4755168	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3516340	USD
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5923190	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	7344462	USD
CY2019	us-gaap	Operating Expenses OperatingExpenses	13780334	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-2094904	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	6097811	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-11534711	USD
CY2020	nuro	Collaboration Income CollaborationIncome	0	USD
CY2019	nuro	Collaboration Income CollaborationIncome	7716667	USD
CY2020	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	2709	USD
CY2019	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	45030	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2709	USD
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	7761697	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-2092195	USD
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.69
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-3.90
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	190331	USD
CY2019	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	15106	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-3773014	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	2530234	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	599117	USD
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4143431	USD
CY2020	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	43751	USD
CY2020	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	23437	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-2092195	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	5247775	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-2092195	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-3773014	USD
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	89954	USD
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	124012	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	599117	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	190331	USD
CY2020	nuro	Compensation Obligation Settlement CompensationObligationSettlement	43751	USD
CY2019	nuro	Compensation Obligation Settlement CompensationObligationSettlement	0	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
CY2019	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	49361	USD
CY2020	nuro	Idle Facility Impairment Charge IdleFacilityImpairmentCharge	350000	USD
CY2019	nuro	Idle Facility Impairment Charge IdleFacilityImpairmentCharge	400000	USD
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2020	nuro	Increase Decrease In Collaboration Receivable IncreaseDecreaseInCollaborationReceivable	-189008	USD
CY2019	nuro	Increase Decrease In Collaboration Receivable IncreaseDecreaseInCollaborationReceivable	189008	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	151124	USD
CY2019	us-gaap	Inventory Write Down InventoryWriteDown	2595884	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	35330	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-734629	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-112432	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	897734	USD
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-243536	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-583342	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-572426	USD
CY2020	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-445132	USD
CY2019	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-157644	USD
CY2020	nuro	Increase Decreasein Accrued Product Returns IncreaseDecreaseinAccruedProductReturns	-144000	USD
CY2019	nuro	Increase Decreasein Accrued Product Returns IncreaseDecreaseinAccruedProductReturns	-412658	USD
CY2020	nuro	Increase Decreasein Deferred Collaboration Income IncreaseDecreaseinDeferredCollaborationIncome	0	USD
CY2019	nuro	Increase Decreasein Deferred Collaboration Income IncreaseDecreaseinDeferredCollaborationIncome	-1956522	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2066861	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3621253	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	48076	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-48076	USD
CY2020	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	4166868	USD
CY2019	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	15106	USD
CY2020	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	773200	USD
CY2019	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	USD
CY2020	us-gaap	Repayments Of Debt RepaymentsOfDebt	773200	USD
CY2019	us-gaap	Repayments Of Debt RepaymentsOfDebt	0	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4166868	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	15106	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2100007	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3654223	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3126206	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6780429	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5226213	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3126206	USD
CY2020	nuro	Stock Issuance Settle Incentive Compensation Obligation StockIssuanceSettleIncentiveCompensationObligation	43751	USD
CY2019	nuro	Stock Issuance Settle Incentive Compensation Obligation StockIssuanceSettleIncentiveCompensationObligation	0	USD
CY2019	nuro	Compensation Obligation Settlement CompensationObligationSettlement	0	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-196900000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5200000	USD
CY2020	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates and Assumptions</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with United States generally accepted accounting principles requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during reporting periods. Actual results could differ from those estimates.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company bases its estimates on historical experience and various other assumptions that it believes to be reasonable under the circumstances and regularly assesses these estimates, but actual results could differ materially from these estimates. Effects of changes in estimates are recorded in the period in which they occur.</span></div>
CY2020	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash equivalents and trade receivables. The Company invests its cash equivalents in highly rated institutions and limits its investment in any individual account to not exceed FDIC limits.</span></div>At December 31, 2020 and 2019, two customers accounted for 50% and 42% of accounts receivable, respectively. Two customers accounted for 35% of revenues for the year ended December 31, 2020 and one customer accounted for 19% of revenues, for the year ended December 31, 2019.
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	25000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	70000	USD
CY2020Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	49600	USD
CY2019Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	75300	USD
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	3014497	shares
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	968116	shares
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.69
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-2092195	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2092195	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-3773014	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3773014	USD
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-3.90
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	215794	shares
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	561654	shares
CY2020	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	210548	USD
CY2019	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	1652171	USD
CY2020	nuro	Sales Revenue Goods Net Percentage From Foreign Country SalesRevenueGoodsNetPercentageFromForeignCountry	0.15
CY2019	nuro	Sales Revenue Goods Net Percentage From Foreign Country SalesRevenueGoodsNetPercentageFromForeignCountry	0.13
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.019
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.700
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.724
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.008
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	164980	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.16
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	361956	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	28	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	5875.19
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	200000	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.57
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	2996	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	31.57
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.68
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y2M12D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	161158	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	6.25
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P8Y6M
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	161158	shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	USD
CY2020Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	197162	USD
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	361956	shares
CY2020Q4	nuro	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Weighted Average Price Per Shares ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAveragePricePerShares	3.68
CY2020	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P0Y9M18D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	6.25
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y6M
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.57
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.58
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	599117	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	190331	USD
CY2020Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	49837	USD
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2019	us-gaap	Inventory Write Down InventoryWriteDown	2595884	USD
CY2020Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	716848	USD
CY2019Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	720209	USD
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	334434	USD
CY2019Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	443505	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	1051282	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	1163714	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	183494	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1504864	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1504864	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1321370	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1231416	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	273448	USD
CY2020	us-gaap	Depreciation Depreciation	89954	USD
CY2019	us-gaap	Depreciation Depreciation	124012	USD
CY2020Q4	nuro	Technology Fees TechnologyFees	450000	USD
CY2019Q4	nuro	Technology Fees TechnologyFees	450000	USD
CY2020Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	343000	USD
CY2019Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	454000	USD
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	333952	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	998442	USD
CY2020	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	0	USD
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1443574	USD
CY2019Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	62322	USD
CY2020Q4	us-gaap	Accrued Advertising Current AccruedAdvertisingCurrent	31000	USD
CY2019Q4	us-gaap	Accrued Advertising Current AccruedAdvertisingCurrent	68000	USD
CY2020Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	49600	USD
CY2019Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	75300	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	75005	USD
CY2019	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	0	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.046
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.199
CY2019	nuro	Effective Income Tax Rate Reconciliation382 Limitation EffectiveIncomeTaxRateReconciliation382Limitation	-8.615
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.003
CY2020	nuro	Effective Income Tax Rate Reconciliation Impact Of Permanent Differences EffectiveIncomeTaxRateReconciliationImpactOfPermanentDifferences	-0.059
CY2019	nuro	Effective Income Tax Rate Reconciliation Impact Of Permanent Differences EffectiveIncomeTaxRateReconciliationImpactOfPermanentDifferences	-0.011
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0
CY2020	nuro	Effective Income Tax Rate Reconciliation382 Limitation EffectiveIncomeTaxRateReconciliation382Limitation	0.019
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.219
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	8.615
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2211161	USD
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1592993	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	43667	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	112995	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	96030	USD
CY2020Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	311639	USD
CY2019Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	306855	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	245988	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	222420	USD
CY2020Q4	nuro	Deferred Tax Assets Right Of Use Assets DeferredTaxAssetsRightOfUseAssets	290268	USD
CY2019Q4	nuro	Deferred Tax Assets Right Of Use Assets DeferredTaxAssetsRightOfUseAssets	0	USD
CY2019Q4	nuro	Deferred Tax Liabilities Lease Liability DeferredTaxLiabilitiesLeaseLiability	0	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	13707	USD
CY2020Q4	nuro	Deferred Tax Liabilities Lease Liability DeferredTaxLiabilitiesLeaseLiability	189498	USD
CY2020Q4	us-gaap	Restructuring Reserve RestructuringReserve	400000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	0	USD
CY2019Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	-9455	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3215718	USD
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2208843	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3012513	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2208843	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2019Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2020Q4	nuro	Income Tax Expense Benefit Attributable To Net Operating Loss Carry Forward IncomeTaxExpenseBenefitAttributableToNetOperatingLossCarryForward	2500000	USD
CY2020Q4	nuro	Income Tax Expense Benefit Attributable To Tax Credit Carry Forwards IncomeTaxExpenseBenefitAttributableToTaxCreditCarryForwards	75000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3000000.0	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2200000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	165785	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1349512	USD
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.147
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	117431	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	653164	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	247347	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	165785	USD
CY2020Q4	nuro	Operating Lease Discount OperatingLeaseDiscount	288470	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	599632	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	461410	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1349512	USD
CY2020	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	667618	USD
CY2019	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	664098	USD
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y
CY2020Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	416562	shares
CY2019	us-gaap	Inventory Write Down InventoryWriteDown	2600000	USD
CY2020	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	0	USD
CY2019	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	0	USD
CY2020Q4	nuro	Restricted Cash Collateral Letters Of Credit RestrictedCashCollateralLettersOfCredit	226731	USD
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3793739	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3793739	shares
CY2020	us-gaap	Common Stock Voting Rights CommonStockVotingRights	Each share of common stock entitles the holder to one vote on all matters submitted to a vote of the Company’s stockholders.
CY2020	nuro	Idle Facility Impairment Charge IdleFacilityImpairmentCharge	350000	USD

Files In Submission

Name	View Source	Status
0001628280-21-001059-index-headers.html	Edgar Link	pending
0001628280-21-001059-index.html	Edgar Link	pending
0001628280-21-001059.txt	Edgar Link	pending
0001628280-21-001059-xbrl.zip	Edgar Link	pending
a10k2020exhibit231.htm	Edgar Link	pending
a10k2020exhibit311.htm	Edgar Link	pending
a10k2020exhibit312.htm	Edgar Link	pending
a10k2020exhibit32.htm	Edgar Link	pending
a10k2020exhibit41.htm	Edgar Link	pending
a10k2020exhibit4314.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
image_01.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nuro-20201231.htm	Edgar Link	pending
nuro-20201231.xsd	Edgar Link	pending
nuro-20201231_cal.xml	Edgar Link	unprocessable
nuro-20201231_def.xml	Edgar Link	unprocessable
nuro-20201231_htm.xml	Edgar Link	completed
nuro-20201231_lab.xml	Edgar Link	unprocessable
nuro-20201231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NURO
NeuroMetrix, Inc. Stock $nuro

2020 Form 10-K Financial Statement

#000162828021001059 Filed on January 29, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NURO NeuroMetrix, Inc. Stock $nuro

2020 Form 10-K Financial Statement

#000162828021001059 Filed on January 29, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NURO
NeuroMetrix, Inc. Stock $nuro